Researchers at the University of Leeds, Queen’s University Belfast and Stellenbosch University in South Africa looked at cannibalism among freshwater shrimp in Northern Ireland.
Dr Alison Dunn, Reader in Evolutionary Biology in the University of Leeds’ Faculty of Biological Sciences, who led the study, said: “Cannibalism is actually fairly common in nature. Our work is the first study to ask if cannibalism is affected by being parasitised.”
The research, published in Royal Society Open Science today, reports that although consumption of juveniles by adults is a normal feature of the shrimp’s feeding patterns, shrimp infected with the parasite ate twice as much of their own kind as uninfected animals.
They attacked juvenile shrimp more often and consumed them more quickly than did uninfected shrimp.
Mandy Bunke, a PhD student at the University of Leeds who was the key researcher on the study, said: “Although the parasite is tiny—similar in size to a human red blood cell—there are millions of them in the host muscle and they all rely on the host for food. This increased demand for food by the parasites may drive the host to be more cannibalistic.”
Dr Dunn added: “The parasite is quite debilitating. It takes over huge areas of the muscle, so instead of a nice transparent shrimp you get quite a chalky appearance because of muscles packed with the parasite. Interestingly, our group has also found previously that infected shrimp may be able to catch and eat less prey of other animal species. Perhaps cannibalism of smaller shrimp is the only way these sick animals can survive.”
The latest study also found that uninfected adult shrimp were less likely to cannibalize infected juvenile shrimp than uninfected juveniles.
Dr Dunn said: “The parasite is passed to its new host either when it dies and is eaten by another shrimp, or when one shrimp cannibalises another. But we observed that uninfected shrimp avoid parasitised food and that is good for the shrimp as it means that they can obtain food through cannibalism but still avoid parasitic infection. Infected shrimp don’t avoid infected juveniles. They consume infected and uninfected juveniles. This may be is because they are more hungry or because they are already infected so there is no incentive to avoid eating infected juveniles.”
Dr Dunn said: “Our research does not suggest any link between parasites and human cannibalism. There is evidence that parasites can affect human behaviour. A study led by Dr Glenn McConkey, also of the University of Leeds Faculty of Biological Sciences, has shown that the parasite Toxoplasma gondii directly affects the chemistry of the human brain. However, cannibalism for the shrimp, unlike in humans, is a significant source of food even in uninfected animals. It seems unlikely that a parasite would be under evolutionary pressure to influence cannibalism in humans.”
However, the study is important to understanding the extent of parasites’ influence on biological systems. The Gammarus duebeni celticus, the subject of the study, is being replaced in Irish waterways by the invasive species Gammarus pulex, which is native to Great Britain. The Open Science study suggests that the parasite Pleistophora mulleri may be playing a role in weakening Gammarus duebeni’s resistance.
Dr Alison Dunn at Leeds and Professor Jaimie Dick at Queen’s University Belfast are available for interview.
Contact: Chris Bunting, Senior Press Officer, University of Leeds; phone: +44 113 343 2049 or email email@example.com.
The full paper: Mandy Bunke et al., ‘Eaten alive: cannibalism enhanced by parasites,’ is published in Royal Society Open Science (2015) and is available at http://dx.doi.org/10.1098/rsos.140369 (DOI: 10.1098/rsos.140369 ).
Dave Westhead and colleagues in Experimental Haematology, Cancer Research UK (Jan 2015), £700,521
Sheena Radford, Mark Harris, Peter Stockley, Alan Berry, Alex O'Neill, Thomas Edwards, Adrian Goldman, Anastasia Zhuravleva, Wellcome Trust (Jan 2015), £443,015
Bill Kunin, EU (Jan 2015), £157,490
John Colyer, Leeds Teaching Hospitals Charitable Fund (Jan 2015), £40,000
Chris Hassall, Royal Society (Dec 2014), £14,500
Ryan Seipke, Royal Society (Nov 2014), £13,700
Alan Berry, Wellcome Trust (Oct 2014), £749,865
Ian Hope, Marie-Anne Shaw, BBSRC (Oct 2014), £396,565
Alison Ashcroft, Peter Stckley, Sheena Radford, Nic Stonehouse, David Brockwell, Darren Tomlinson, BBSRC (Oct 2014), £340,937
Les Firbank, Joe Holden, BBSRC (Oct 2014), £210,302
Darren Tomlinson and colleagues in Chemistry and Pathology, anatomy and Tumour Biology, Dr Hadwen Trusy (Oct 2014), £194,475
Paul Knox, EU (Oct 2014), £167,229
Martin Stacey and colleagues in Medicine & Health, Pfizer (Oct 2014), £90,453
Darren Tomlinson and colleagues in Experimental Oncology, YCR (Oct 2014), £69,480
Andrew Macdonald, Jamel Mankouri, Kidney Research Fund UK (Oct 2014), £58,878
Mike McPherson and colleagues in Dentistry and Engineering, Wellcome Trust (Oct 2014), £58,437
Dave Westhead and colleagues in Experimental Haemotology, Leukaemia & Lymphoma Research (Sep 2014), £281,424
Emmanuel Paci and colleagues in Chemistry, BBSRC (Sep 2014), £636,759
Andrew Peel, BBSRC (Sep 2014), £371,598
Lars Jeuken, Stephen Evans, BBSRC (Sep 2014), £333,684
Lars Jeuken, BBSRC (Sep 2014), £313,463
Michelle Peckham, Mark Harris, Rao Sivaprasadarao, Eileen Ingham, Nic Stonehouse, Nikita Gamper, Wellcome Trust (Sep 2014), £192,763
Neil Ranson, BBSRC (Aug 2014), £355,253
Stuart Egginton, BHF (Aug 2014), £271,094
Darren Tomlinson, Mike McPherson, Technology Strategy Board (Aug 2014), £98,665
Peter Henderson, Leverhulme Trust (Aug 2014), £15,222
Mike McPherson (and colleagues in the School of Chemistry), EPSRC (Jul 2014), £819,880
Peter Stockley, Neil Ranson, BBSRC (Jul 2014), £455,787
Sheena Radford, Univesity of Michigan (Jul 2014), £138,452
Ryan Seipke, British Society Antimicrobial Chemistry (Jun 2014), £11,960
John Trinick, BHF (Jun 2014), £222,614
Chris West, Leverhulme Trust (Jun 2014), £181,241
Jon Lippiat, Darren Tomlinson, BBSRC (May 2014), £125,174
Christine Foyer, Royal Society (May 2014), £24,000
David Brockwell, Sheena Radford, Medimmune Ltd (Apr 2014), £337,661
Peter Stockley, Wellcome Trust (Apr 2014), £251,019
Mike McPherson, Wellcome Trust (Apr 2014), £146,596
Andrew Macdonald, Kidney Research Fund UK (Apr 2014), £127,237
Elwyn Isaac, DEFRA (Apr 2014), £126,512
Mike McPherson (and colleagues in School of Design), Technology Strategy Board (Apr 2014), £114,350
Paul Millner, Peter Stockley, Darren Tomlinson, YCR (Apr 2014), £95,874
Carrie Ferguson, Karen Birch, Shaunna Burke, Heart Research UK (Apr 2014), £60,140
Tim Benton, Technology Strategy Board (Apr 2014), £24,969
Bill Kunin, Technology Strategy Board (Apr 2014), £21,244
Dave Westhead, MRC (Apr 2014), £18,304